所有图片(1)

主要文件

COO原产地证书/COA分析证书

查看所有文档

PHR1721

特拉唑嗪

Name: 特拉唑嗪
Brand: SIAL

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

特拉唑嗪盐酸盐二水合物

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₁₉H₂₅N₅O₄ · HCl · 2H₂O

CAS号:

70024-40-7

分子量:

459.92

MDL编号:

MFCD00941408

UNSPSC代码:

41116107

PubChem化学物质编号:

329823574

NACRES:

NA.24

推荐产品

Slide 1 of 10

1 of 10

Supelco

PHR1565

八甲基环四硅氧烷

Supelco

PHR1236

视黄醇乙酸酯

Supelco

PHR1030

DL-α-生育酚醋酸酯

Supelco

PHR1566

十甲基环五硅氧烷

Supelco

PHR1237

胆钙化醇

Supelco

PHR1234

维生素B12

Supelco

PHR1235

视黄醇(维生素A)棕榈酸酯 CRM

USP

1643452

特拉唑嗪盐酸盐二水合物

Supelco

PHR1372

甲醇

Supelco

PHR1476

邻苯二甲酸二乙酯

等级

certified reference material
pharmaceutical secondary standard

质量水平

300

Agency

traceable to Ph. Eur. Y0000621
traceable to USP 1643452

API类

terazosin

CofA

current certificate can be downloaded

包装

pkg of 1 g

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-30°C

SMILES字符串

O.O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

InChI

1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2

InChI key

NZMOFYDMGFQZLS-UHFFFAOYSA-N

基因信息

human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146)

正在寻找类似产品? 访问产品对比指南

一般描述

Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Terazosin Hydrochloride belongs to the class of a₁-adrenergic blockers, widely used for the treatment of benign prostatic hyperplasia (BPH) affecting the urogenital tract in men.
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

应用

It may be used as drug standard stock solution for determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.

Terazosin Hydrochloride may be used as a drug standard stock solution for the determination of terazosin hydrochloride dihydrate using potentiometric and fluorimetric techniques.
Terazosin Hydrochloride may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using high-performance thin layer chromatography.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAA7395 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

Y0000622

特拉唑嗪杂质A, European Pharmacopoeia (EP) Reference Standard

1643463

1643474

1643485

PHR3137

象形图

GHS07

警示用语：

Warning

危险声明

H319

预防措施声明

P264 - P280 - P305 + P351 + P338 - P337 + P313

危险分类

Eye Irrit. 2

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number

抱歉，我们目前尚未线上提供该产品的COA。

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations

Belal.ST, et al.

Analytical Chemistry Research, 1, 23-31 (2014)

Potentiometric and fluorimetric methods for the determination of terazosin HCl in drug substance and dosage forms.

Ismail, Nahla S., and Taghreed A. Mohamed.

International Journal of Electrochemical Science, 9, 7394-7394 (2014)

Terazosin potentiometric sensor for quantitative analysis of terazosin hydrochloride in pharmaceutical formulation based on computational study.

Hosseini, Morteza, Ensieh Nasli-Esfahani, and Parviz Norouzi.

International Journal of Electrochemical Science, 5, 200-214 (2010)

主要文件

特拉唑嗪

Pharmaceutical Secondary Standard; Certified Reference Material

About This Item

推荐产品

属性

等级

质量水平

Agency

API类

CofA

包装

技术

应用

包装形式

储存温度

SMILES字符串

InChI

InChI key

基因信息

相关类别

说明

一般描述

应用

分析说明

其他说明

附注

相关产品

相关产品

安全信息

象形图

警示用语：

危险声明

预防措施声明

危险分类

储存分类代码

WGK

闪点(°F)

闪点(°C)

文件

分析证书(COA)

已有该产品？

同行评审论文

技术文章和实验方案

相关内容

技术服务